Recap: Adamis Pharmaceuticals Q2 Earnings

 

Adamis Pharmaceuticals ADMP reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Adamis Pharmaceuticals missed estimated earnings by 100.0%, reporting an EPS of $-0.06 versus an estimate of $-0.03.

Revenue was down $3.97 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 8.03% drop in the share price the next day.

 

To track all earnings releases for Adamis Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!